Bridgewater Associates, LPBridgewater Associates, LP

Institutional investor · Portfolio as of Q3 2019

SEC EDGAR SourceSEC Filings

Top Holdings333 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
SPYSPY
Unit

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

7M$2.1B18.4%$226.33+19.02%
4 qtrssince 2018-Q4
Increased
64
VWOVWO
ETF

VANGUARD FTSE EMERGING MARKETS

37.4M$1.5B13.2%$31.82+3.73%
4 qtrssince 2018-Q4
Decreased
0
IEMGIEMG
ETF

ISHARES CORE MSCI EMERGING

17.3M$848.1M7.5%$41.13-1.65%
4 qtrssince 2018-Q4
Decreased
0
IVVIVV
ETF

ISHARES CORE S&P 500 ETF

2.2M$653.2M5.7%$222.91+20.91%
4 qtrssince 2018-Q4
Increased
61
GLDGLD
ETF

SPDR GOLD TRUST

4.1M$563.3M4.9%$121.17+16.41%
4 qtrssince 2018-Q4
Unchanged
0
EWZEWZ
ETF

ISHARES MSCI BRAZIL ETF

12.7M$534.6M4.7%$26.50+3.69%
4 qtrssince 2018-Q4
Increased
74
EEMEEM
ETF

ISHARES MSCI EMERGING MARKETS INDEX FUND

12.6M$513.5M4.5%$36.14-3.60%
4 qtrssince 2018-Q4
Decreased
0
LQDLQD
ETF

ISHARES IBOXX INVESTMENT GRA

2.3M$297.2M2.6%$86.52+15.31%
4 qtrssince 2018-Q4
Decreased
0
TLTTLT
ETF

ISHARES 20 PLUS YEAR TREASURY BD

1.9M$273.1M2.4%$99.88+19.14%
4 qtrssince 2018-Q4
Decreased
0
HYGHYG
ETF

ISHR IBX USD HIYLD CB ETF-UI

3.1M$267.2M2.3%$55.33+8.88%
4 qtrssince 2018-Q4
Decreased
0
EWYEWY
ETF

ISHARES MSCI SOUTH KOREA ETF

3.5M$199.8M1.8%$51.94-6.66%
4 qtrssince 2018-Q4
Decreased
0
EFAEFA
ETF

ISHARES MSCI EAFE ETF CL USD INC

2.7M$177M1.6%$48.09+11.68%
4 qtrssince 2018-Q4
Increased
51
VEAVEA
ETF

VANGUARD FTSE DEVELOPED ETF

4.3M$175.7M1.5%$30.19+11.60%
4 qtrssince 2018-Q4
Increased
51
IAUIAU
ETF

ISHARES

11.7M$164.7M1.4%
IEFAIEFA
ETF

ISHARES CORE MSCI EAFE ETF

2.7M$163.1M1.4%$44.76+11.79%
4 qtrssince 2018-Q4
Increased
51
EMBEMB
ETF

ISHARES TR

1.3M$152.1M1.3%$74.46+12.49%
4 qtrssince 2018-Q4
Decreased
0
EWTEWT
ETF

ISHARES INC MSCI TAIWAN ETF

4M$145.3M1.3%$23.460.00%
1 qtr
New
69
INDAINDA
ETF

ISHARES MSCI INDIA ETF

3.7M$122.7M1.1%$32.40-4.33%
3 qtrssince 2019-Q1
Increased
57

BREAD FINANCIAL HOLDINGS INC

566,844$72.6M0.6%$101.89-11.46%
4 qtrssince 2018-Q4
Increased
44

BIOGEN IDEC INC

237,455$55.3M0.5%$246.83-6.73%
4 qtrssince 2018-Q4
Decreased
0
$11.4B
AUM
333
Positions
Q3 2019
Filing
Rating · 2.5
Quarterly Portfolio Change
+49%Q1'19$16.3B-22%Q2'19$12.8B-11%Q3'19$11.4B
Activity profile
$ moved · Q3'19
New11%Increased20%Decreased58%Exited10%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.4 quarters
<1Q9%1-4Q91%1-2Y0%2Y+0%

Bridgewater Associates, LP manages $11.4B across 333 positions as of Q3 2019. Top holdings: SPY (18.4%), VWO (13.2%), IEMG (7.5%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2.5/5.0.

Q3 2019 Summary

Active quarter - 110 new positions, 82 exits, 105 increased. Top move: EWZ (INCREASED, conviction 74). Portfolio: $11.4B across 333 positions.

Top holdings by portfolio weight

Total AUM$11B
SPY18.35%
VWO13.22%
IEMG7.45%
IVV5.74%
GLD4.95%
EWZ4.70%
EEM4.51%
LQD2.61%
TLT2.40%
HYG2.35%
Other1.75%

Portfolio allocation by GICS sector

Sectors11
Unknown82.69%
Consumer Cyclical3.40%
Financial Services3.10%
Healthcare2.48%
Energy2.18%
Basic Materials1.51%
Industrials1.21%
Communication Services1.05%
Technology0.76%
Real Estate0.67%
Other0.95%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track Record58
Conviction44
Concentration60
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
BCOBCOBRINK'S CO/THE
Q3 2025 Q2 2026+77,590 shares+$7.4M
4Q
FLOFLOFLOWERS FOODS INC
Q3 2025 Q2 2026+351,417 shares+$2.7M
4Q
GISGISGENERAL MILLS INC
Q3 2025 Q2 2026+62,114 shares+$1.6M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used